[Neurological problems in malignant hemopathies in children. II. Neurotoxicity of antiblastic drugs and radiotherapy].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D002493:Central Nervous System Diseases / Q000209:etiology*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000150:complications* / Q000628:therapy; D008223:Lymphoma / Q000150:complications* / Q000628:therapy; D008727:Methotrexate / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects*; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D003561:Cytarabine; D014750:Vincristine; D001215:Asparaginase; D008727:Methotrexate
Problemi neurologici nelle emopatie maligne del bambino. Nota II. - Neurotossicità dei farmaci antiblastici e della radioterapia.